Based on previous data, we chose tumour-related mRNA (CEA, CK19, survivin) for the detection of circulating tumour cells in gastric cancer patients with the use of a reverse-transcriptase polymerase chain reaction (real-time PCR) method [42,43,44]. This evidence concerns the gene CEACAM5 and neoplasm.